NCT02208388Recruiting
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Source: ClinicalTrials.gov · Last updated 5 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to evaluate safety and effectiveness of CTP(computed tomography perfusion) guided revascularization vs FFR(Fractional flow reserve) guided revascularization
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 31 Jul 2014
- Start date
- 12 Aug 2014
- Primary completion date
- 5 Mar 2028
- Lead sponsor
- Young-Hak Kim, MD, PhD
- Diseases
- Coronary artery disease
- NCT number
- NCT02208388
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 12 Aug 2014 to the primary completion date, 5 Mar 2028
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Requirement for surgical procedure
- Undergoing evaluation for organ transplantation
- Inability to take dual antiplatelet therapy for six months
- Previous CABG
Other illness
- Non STEMI, if the cardiac troponin is not stable or starting to decline
- Left main disease requiring revascularization
- Severe and persistent angina with severe limitation in everyday living activities (Canadian Cardiovascular Society grading Class IV)
Lab values
- Left ventricular ejection fraction \<30%
- Impaired renal function with an effective glomerular filtration rate less than 30mL/min/1.73 ㎡ or creatinine more than 2.0 mg/dL
Age
- Life expectancy \<2 years
Other
- Cardiogenic shock and/or need for mechanical/pharmacologic hemodynamic support
- Recent STEMI (\<5 days)
- Participation or planned participation in another cardiovascular clinical trial
- Pregnancy
- Any target lesion with in-stent restenosis
- NYHA class 3 or 4a
Who the study is looking for
- Age 20 and more
- Diagnosed angina or angina equivalent symptom or positive exercise treadmill test
- Patients with intermediate- or high-risk probability of CAD defined by Diamond and Forester
- 70 % stenosis or more in coronary CTA
- Willing to provide informed, written consent
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hallym University Sacred Heart Hospital Coordinator of this site? Confirm its status | Anyang | South Korea | Completed |
| Gangwon National Univ. Hospital Coordinator of this site? Confirm its status | Chuncheon | South Korea | Completed |
| Keimyung University - Dongsan Medical Center Coordinator of this site? Confirm its status | Daegu | South Korea | Completed |
| Pusan National University Hospital Coordinator of this site? Confirm its status | Pusan | South Korea | Enrolling by invitation |
| Pusan National University Yangsan Hospital Coordinator of this site? Confirm its status | Pusan | South Korea | Completed |
| Asan Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
| Severance hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Withdrawn |
This page is information, not medical advice. Discuss any trial with your doctor.